IONS logo

Ionis Pharmaceuticals, Inc. (IONS) Free Cash Flow

Annual FCF:

-$551.29M-$215.76M(-64.31%)
December 31, 2024

Summary

  • As of today, IONS annual free cash flow is -$551.29 million, with the most recent change of -$215.76 million (-64.31%) on December 31, 2024.
  • During the last 3 years, IONS annual free cash flow has fallen by -$564.19 million (-4374.21%).
  • IONS annual free cash flow is now -194.20% below its all-time high of $585.24 million, reached on December 31, 2018.

Performance

IONS Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIONScash flow metrics

Quarterly FCF:

-$138.37M-$275.44M(-200.95%)
September 1, 2025

Summary

  • As of today, IONS quarterly free cash flow is -$138.37 million, with the most recent change of -$275.44 million (-200.95%) on September 1, 2025.
  • Over the past year, IONS quarterly free cash flow has dropped by -$27.07 million (-24.32%).
  • IONS quarterly free cash flow is now -128.10% below its all-time high of $492.49 million, reached on June 30, 2018.

Performance

IONS Quarterly Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIONScash flow metrics

TTM FCF:

-$309.48M-$27.07M(-9.59%)
September 1, 2025

Summary

  • As of today, IONS TTM free cash flow is -$309.48 million, with the most recent change of -$27.07 million (-9.59%) on September 1, 2025.
  • Over the past year, IONS TTM free cash flow has increased by +$64.73 million (+17.30%).
  • IONS TTM free cash flow is now -145.61% below its all-time high of $678.60 million, reached on March 31, 2019.

Performance

IONS TTM Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIONScash flow metrics

Free Cash Flow Formula

FCF = Cash From Operations − CAPEX

IONS Free Cash Flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-64.3%-24.3%+17.3%
3Y3 Years-4374.2%-339.4%-380.3%
5Y5 Years-278.2%-495.2%-273.8%

IONS Free Cash Flow Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-4374.2%at low-200.9%+32.6%-380.3%+46.0%
5Y5-Year-278.2%at low-169.3%+32.6%-273.8%+46.0%
All-TimeAll-Time-194.2%at low-128.1%+32.6%-145.6%+46.0%

IONS Free Cash Flow History

DateAnnualQuarterlyTTM
Sep 2025
-
-$138.37M(-200.9%)
-$309.48M(-9.6%)
Jun 2025
-
$137.07M(+183.6%)
-$282.41M(+49.5%)
Mar 2025
-
-$164.00M(-13.7%)
-$559.62M(-1.5%)
Dec 2024
-$551.29M(-64.3%)
-$144.18M(-29.5%)
-$551.29M(-47.3%)
Sep 2024
-
-$111.30M(+20.6%)
-$374.21M(+0.3%)
Jun 2024
-
-$140.14M(+10.0%)
-$375.18M(-8.6%)
Mar 2024
-
-$155.67M(-573.3%)
-$345.48M(-3.0%)
Dec 2023
-$335.52M(-13.9%)
$32.89M(+129.3%)
-$335.52M(+41.5%)
Sep 2023
-
-$112.26M(-1.7%)
-$573.62M(-16.4%)
Jun 2023
-
-$110.44M(+24.2%)
-$492.84M(-21.7%)
Mar 2023
-
-$145.72M(+29.0%)
-$405.00M(-37.5%)
Dec 2022
-$294.47M(-2383.1%)
-$205.20M(-551.7%)
-$294.47M(-366.7%)
Sep 2022
-
-$31.49M(-39.3%)
$110.43M(+35.1%)
Jun 2022
-
-$22.60M(+35.8%)
$81.75M(+131.1%)
Mar 2022
-
-$35.18M(-117.6%)
$35.38M(+174.3%)
Dec 2021
$12.90M(+350.2%)
$199.70M(+431.9%)
$12.90M(+113.5%)
Sep 2021
-
-$60.17M(+12.7%)
-$95.70M(-62.8%)
Jun 2021
-
-$68.96M(-19.6%)
-$58.77M(-29.9%)
Mar 2021
-
-$57.66M(-163.3%)
-$45.24M(-777.5%)
Dec 2020
-$5.16M(-101.7%)
$91.10M(+491.9%)
-$5.16M(-102.9%)
Sep 2020
-
-$23.25M(+58.1%)
$178.11M(+4.3%)
Jun 2020
-
-$55.44M(-215.4%)
$170.76M(-11.9%)
Mar 2020
-
-$17.58M(-106.4%)
$193.79M(-38.4%)
Dec 2019
$309.44M(-47.1%)
$274.37M(+996.9%)
$314.81M(+104.7%)
Sep 2019
-
-$30.59M(+5.6%)
$153.82M(+0.1%)
Jun 2019
-
-$32.40M(-131.3%)
$153.71M(-77.3%)
Mar 2019
-
$103.44M(-8.8%)
$678.60M(+16.0%)
Dec 2018
$585.24M(+329.4%)
$113.38M(+469.2%)
$585.24M(+20.6%)
Sep 2018
-
-$30.71M(-106.2%)
$485.19M(-7.6%)
Jun 2018
-
$492.49M(+4783.8%)
$524.88M(+1779.2%)
Mar 2018
-
$10.08M(-24.4%)
$27.93M(-79.5%)
Dec 2017
$136.29M(+210.2%)
$13.34M(+48.6%)
$136.29M(+46.3%)
Sep 2017
-
$8.97M(+301.1%)
$93.16M(-11.6%)
Jun 2017
-
-$4.46M(-103.8%)
$105.36M(+47.2%)
Mar 2017
-
$118.44M(+497.5%)
$71.59M(+157.9%)
Dec 2016
-$123.63M(-1418.5%)
-$29.80M(-240.7%)
-$123.63M(+8.0%)
Sep 2016
-
$21.18M(+155.4%)
-$134.44M(-13.0%)
Jun 2016
-
-$38.23M(+50.2%)
-$118.99M(-484.3%)
Mar 2016
-
-$76.78M(-89.1%)
-$20.36M(-269.8%)
Dec 2015
$9.38M(+294.6%)
-$40.61M(-210.9%)
$11.99M(-89.9%)
Sep 2015
-
$36.63M(-39.4%)
$118.59M(+43.9%)
Jun 2015
-
$60.40M(+236.0%)
$82.39M(+642.8%)
Mar 2015
-
-$44.42M(-167.3%)
-$15.18M(-215.0%)
Dec 2014
-$4.82M(-108.3%)
$65.99M(>+9900.0%)
-$4.82M(+94.2%)
Sep 2014
-
$423.00K(+101.1%)
-$83.02M(-297.9%)
Jun 2014
-
-$37.17M(-9.1%)
-$20.87M(-154.6%)
Mar 2014
-
-$34.06M(-179.0%)
$38.21M(-37.1%)
Dec 2013
$58.13M(+1864.8%)
-$12.21M(-119.5%)
$60.77M(-43.6%)
Sep 2013
-
$62.58M(+185.7%)
$107.66M(+471.1%)
Jun 2013
-
$21.90M(+290.5%)
$18.85M(+347.4%)
Mar 2013
-
-$11.50M(-133.2%)
-$7.62M(-131.4%)
Dec 2012
-$3.29M(+97.4%)
$34.68M(+232.2%)
-$3.29M(+94.8%)
Sep 2012
-
-$26.23M(-473.8%)
-$63.10M(+1.1%)
Jun 2012
-
-$4.57M(+36.3%)
-$63.79M(+29.2%)
Mar 2012
-
-$7.17M(+71.5%)
-$90.04M(+28.4%)
Dec 2011
-$125.80M(-55.0%)
-$25.13M(+6.6%)
-$125.80M(+1.4%)
Sep 2011
-
-$26.91M(+12.7%)
-$127.56M(-3.0%)
Jun 2011
-
-$30.83M(+28.2%)
-$123.89M(-36.4%)
Mar 2011
-
-$42.93M(-59.7%)
-$90.86M(-12.0%)
Dec 2010
-$81.15M(+34.9%)
-$26.89M(-15.7%)
-$81.15M(+8.3%)
Sep 2010
-
-$23.25M(-1153.9%)
-$88.51M(+10.9%)
Jun 2010
-
$2.21M(+106.6%)
-$99.33M(+17.4%)
Mar 2010
-
-$33.22M(+3.0%)
-$120.25M(+3.6%)
Dec 2009
-$124.73M(-164.0%)
-$34.25M(-0.5%)
-$124.73M(-6.5%)
Sep 2009
-
-$34.07M(-82.1%)
-$117.09M(-7.7%)
Jun 2009
-
-$18.71M(+50.4%)
-$108.74M(-230.1%)
Mar 2009
-
-$37.70M(-41.7%)
$83.61M(-57.1%)
Dec 2008
$194.96M
-$26.61M(-3.4%)
$194.96M(-26.8%)
Sep 2008
-
-$25.72M(-114.8%)
$266.28M(-12.4%)
DateAnnualQuarterlyTTM
Jun 2008
-
$173.64M(+135.7%)
$303.92M(+136.5%)
Mar 2008
-
$73.66M(+64.8%)
$128.48M(+283.6%)
Dec 2007
$31.08M(+155.7%)
$44.70M(+275.1%)
$33.49M(+267.3%)
Sep 2007
-
$11.92M(+762.5%)
-$20.02M(+57.0%)
Jun 2007
-
-$1.80M(+91.6%)
-$46.57M(+21.6%)
Mar 2007
-
-$21.33M(-142.2%)
-$59.42M(-9.5%)
Dec 2006
-$55.78M(+13.7%)
-$8.81M(+39.8%)
-$54.27M(+12.9%)
Sep 2006
-
-$14.62M(+0.2%)
-$62.30M(-16.3%)
Jun 2006
-
-$14.65M(+9.4%)
-$53.56M(+8.4%)
Mar 2006
-
-$16.18M(+3.9%)
-$58.48M(+9.5%)
Dec 2005
-$64.61M(+42.1%)
-$16.84M(-186.5%)
-$64.61M(+12.3%)
Sep 2005
-
-$5.88M(+70.0%)
-$73.66M(+18.7%)
Jun 2005
-
-$19.58M(+12.2%)
-$90.64M(+12.9%)
Mar 2005
-
-$22.31M(+13.8%)
-$104.02M(+1.2%)
Dec 2004
-$111.69M(-2.1%)
-$25.89M(-13.2%)
-$105.28M(+7.0%)
Sep 2004
-
-$22.86M(+30.6%)
-$113.21M(+0.6%)
Jun 2004
-
-$32.95M(-39.8%)
-$113.90M(-8.4%)
Mar 2004
-
-$23.57M(+30.3%)
-$105.04M(-2.0%)
Dec 2003
-$109.43M(+22.3%)
-$33.83M(-43.6%)
-$103.03M(-10.7%)
Sep 2003
-
-$23.55M(+2.2%)
-$93.08M(+0.6%)
Jun 2003
-
-$24.09M(-11.7%)
-$93.64M(+28.4%)
Mar 2003
-
-$21.56M(+9.7%)
-$130.81M(+0.3%)
Dec 2002
-$140.75M(-219.0%)
-$23.87M(+1.0%)
-$131.22M(-7.2%)
Sep 2002
-
-$24.11M(+60.6%)
-$122.41M(-71.3%)
Jun 2002
-
-$61.27M(-179.0%)
-$71.44M(-271.2%)
Mar 2002
-
-$21.96M(-45.7%)
-$19.25M(-24.6%)
Dec 2001
-$44.12M(-57.5%)
-$15.07M(-156.1%)
-$15.45M(-198.8%)
Sep 2001
-
$26.85M(+396.0%)
-$5.17M(+83.7%)
Jun 2001
-
-$9.07M(+50.0%)
-$31.75M(-1.3%)
Mar 2001
-
-$18.16M(-278.9%)
-$31.34M(-26.2%)
Dec 2000
-$28.02M(+49.8%)
-$4.79M(-1901.5%)
-$24.84M(+23.4%)
Sep 2000
-
$266.00K(+103.1%)
-$32.42M(+26.7%)
Jun 2000
-
-$8.65M(+25.7%)
-$44.22M(+9.6%)
Mar 2000
-
-$11.65M(+5.8%)
-$48.92M(+8.0%)
Dec 1999
-$55.80M(-42.4%)
-$12.38M(-7.3%)
-$53.16M(-1.3%)
Sep 1999
-
-$11.53M(+13.6%)
-$52.45M(-2.0%)
Jun 1999
-
-$13.35M(+16.0%)
-$51.41M(-39.7%)
Mar 1999
-
-$15.89M(-36.1%)
-$36.79M(+6.0%)
Dec 1998
-$39.18M(-50.1%)
-$11.68M(-11.4%)
-$39.15M(-17.0%)
Sep 1998
-
-$10.48M(-932.0%)
-$33.48M(-31.3%)
Jun 1998
-
$1.26M(+106.9%)
-$25.49M(+29.1%)
Mar 1998
-
-$18.25M(-204.2%)
-$35.95M(-49.2%)
Dec 1997
-$26.11M(-18.6%)
-$6.00M(-140.0%)
-$24.10M(+0.4%)
Sep 1997
-
-$2.50M(+72.8%)
-$24.20M(+12.6%)
Jun 1997
-
-$9.20M(-43.8%)
-$27.70M(-3.7%)
Mar 1997
-
-$6.40M(-4.9%)
-$26.70M(-20.8%)
Dec 1996
-$22.01M(-36.3%)
-$6.10M(-1.7%)
-$22.10M(+6.4%)
Sep 1996
-
-$6.00M(+26.8%)
-$23.60M(-38.0%)
Jun 1996
-
-$8.20M(-355.6%)
-$17.10M(-37.9%)
Mar 1996
-
-$1.80M(+76.3%)
-$12.40M(+23.5%)
Dec 1995
-$16.15M(-0.4%)
-$7.60M(-1620.0%)
-$16.20M(-33.9%)
Sep 1995
-
$500.00K(+114.3%)
-$12.10M(+16.0%)
Jun 1995
-
-$3.50M(+37.5%)
-$14.40M(0.0%)
Mar 1995
-
-$5.60M(-60.0%)
-$14.40M(+10.6%)
Dec 1994
-$16.10M(+21.4%)
-$3.50M(-94.4%)
-$16.10M(+7.5%)
Sep 1994
-
-$1.80M(+48.6%)
-$17.40M(+8.4%)
Jun 1994
-
-$3.50M(+52.1%)
-$19.00M(+14.8%)
Mar 1994
-
-$7.30M(-52.1%)
-$22.30M(-8.8%)
Dec 1993
-$20.49M(+4.6%)
-$4.80M(-41.2%)
-$20.50M(-5.7%)
Sep 1993
-
-$3.40M(+50.0%)
-$19.40M(+10.2%)
Jun 1993
-
-$6.80M(-23.6%)
-$21.60M(-9.1%)
Mar 1993
-
-$5.50M(-48.6%)
-$19.80M(+7.9%)
Dec 1992
-$21.48M(-387.3%)
-$3.70M(+33.9%)
-$21.50M(-11.4%)
Sep 1992
-
-$5.60M(-12.0%)
-$19.30M(-14.9%)
Jun 1992
-
-$5.00M(+30.6%)
-$16.80M(-21.7%)
Mar 1992
-
-$7.20M(-380.0%)
-$13.80M(-213.6%)
Dec 1991
-$4.41M
-$1.50M(+51.6%)
-$4.40M(-51.7%)
Sep 1991
-
-$3.10M(-55.0%)
-$2.90M(-1550.0%)
Jun 1991
-
-$2.00M(-190.9%)
$200.00K(-90.9%)
Mar 1991
-
$2.20M
$2.20M

FAQ

  • What is Ionis Pharmaceuticals, Inc. annual free cash flow?
  • What is the all-time high annual free cash flow for Ionis Pharmaceuticals, Inc.?
  • What is Ionis Pharmaceuticals, Inc. annual free cash flow year-on-year change?
  • What is Ionis Pharmaceuticals, Inc. quarterly free cash flow?
  • What is the all-time high quarterly free cash flow for Ionis Pharmaceuticals, Inc.?
  • What is Ionis Pharmaceuticals, Inc. quarterly free cash flow year-on-year change?
  • What is Ionis Pharmaceuticals, Inc. TTM free cash flow?
  • What is the all-time high TTM free cash flow for Ionis Pharmaceuticals, Inc.?
  • What is Ionis Pharmaceuticals, Inc. TTM free cash flow year-on-year change?

What is Ionis Pharmaceuticals, Inc. annual free cash flow?

The current annual free cash flow of IONS is -$551.29M

What is the all-time high annual free cash flow for Ionis Pharmaceuticals, Inc.?

Ionis Pharmaceuticals, Inc. all-time high annual free cash flow is $585.24M

What is Ionis Pharmaceuticals, Inc. annual free cash flow year-on-year change?

Over the past year, IONS annual free cash flow has changed by -$215.76M (-64.31%)

What is Ionis Pharmaceuticals, Inc. quarterly free cash flow?

The current quarterly free cash flow of IONS is -$138.37M

What is the all-time high quarterly free cash flow for Ionis Pharmaceuticals, Inc.?

Ionis Pharmaceuticals, Inc. all-time high quarterly free cash flow is $492.49M

What is Ionis Pharmaceuticals, Inc. quarterly free cash flow year-on-year change?

Over the past year, IONS quarterly free cash flow has changed by -$27.07M (-24.32%)

What is Ionis Pharmaceuticals, Inc. TTM free cash flow?

The current TTM free cash flow of IONS is -$309.48M

What is the all-time high TTM free cash flow for Ionis Pharmaceuticals, Inc.?

Ionis Pharmaceuticals, Inc. all-time high TTM free cash flow is $678.60M

What is Ionis Pharmaceuticals, Inc. TTM free cash flow year-on-year change?

Over the past year, IONS TTM free cash flow has changed by +$64.73M (+17.30%)
On this page